Pandion Therapeutics, Inc. is a clinical stage biopharmaceutical company. It develops Therapeutic Autoimmune reguLatOry proteiN (TALON) drug design and discovery platform, which employ a modular approach to create a pipeline of product candidates using immunomodulatory effector modules that act at known control nodes within the immune network. The company was founded by Dr. Joanne Viney on September 19, 2016 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Pandion Therapeutics Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Pandion Therapeutics Inc market cap is $1.77B.
What is the 52-week high for Pandion Therapeutics Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Pandion Therapeutics Inc 52 week high is $62.90 as of October 10, 2025.
What is the 52-week low for Pandion Therapeutics Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Pandion Therapeutics Inc 52 week low is $10.28 as of October 10, 2025.
What is Pandion Therapeutics Inc stock price today?
Pandion Therapeutics Inc stock price today is $60.05.
What was Pandion Therapeutics Inc stock price yesterday?
Pandion Therapeutics Inc stock price yesterday was $59.92.
What is the PE ratio of Pandion Therapeutics Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Pandion Therapeutics Inc’s P/E ratio is -39.69.
What is the Price-to-Book ratio of Pandion Therapeutics Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Pandion Therapeutics Inc P/B ratio is 7.9371.
What is the 50-day moving average of Pandion Therapeutics Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Pandion Therapeutics Inc 50-day moving average is $40.85.